Scholarlink

<p>This study aims to investigate the effects of photobiomodulation (PBM) on the treatment of head and neck squamous cell carcinoma (HNSCC) with Radiation Therapy (RT).&#xa0;An experimental in vivo study was conducted using a 4-nitroquinoline-1-oxide (4NQO)-induced oral carcinogenesis model in Swiss mice (<i>n</i> = 50), which were randomly divided into four groups. The control group (<i>n</i> = 5) received no treatment, while all other groups (<i>n</i> = 15 each) were exposed to 4NQO via drinking water. One group received only 4NQO, another received 4NQO followed by localized radiotherapy (16&#xa0;Gy) to the oral region, and the final group received photobiomodulation before radiotherapy using a 660&#xa0;nm laser (9&#xa0;J, 300&#xa0;J/cm²). Histological and immunohistochemical analyses (VEGF, Bax) were performed to assess tissue response and molecular changes. Ethical approval: nº001/2023.&#xa0;PBM associated with radiotherapy appears to have a potential radiosensitizing effect, as the results showed a decrease in the incidence of oral squamous cell carcinoma in the group in which PBM was applied prior to irradiation. The animals that did not receive PBM had a 9-fold risk of developing cancer compared to those treated with PBM before radiotherapy. VEGF expression was significantly reduced in all groups treated with 4NQO, regardless of whether radiotherapy or PBM was applied, compared to the control group. On the other hand, BAX expression increased significantly in the group subjected to the combination of PBM and radiotherapy, indicating a possible pro-apoptotic effect of PBM when associated with radiation.&#xa0;PBM shows potential as an effective pre-radiotherapy intervention, contributing to the prevention of HNSCC and modulation of tumor-related molecular pathways.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Photobiomodulation enhances radiosensitivity and suppresses oral squamous cell carcinoma in a 4NQO-induced mouse model

  • 期刊论文

  • 发表日期：

    2025年12月2日

查看全文
  • Cristina Paixão Durães,
  • Larissa Lopes Fonseca,
  • Lorena dos Reis Pereira Queiroz,
  • Ricardo Santiago Gomez,
  • Victor Hugo Dantas Guimarães,
  • Sérgio Henrique Sousa Santos,
  • Alfredo Maurício Batista de Paula,
  • Lucyana Conceição Farias,
  • André Luiz Sena Guimarães

摘要

This study aims to investigate the effects of photobiomodulation (PBM) on the treatment of head and neck squamous cell carcinoma (HNSCC) with Radiation Therapy (RT). An experimental in vivo study was conducted using a 4-nitroquinoline-1-oxide (4NQO)-induced oral carcinogenesis model in Swiss mice (n = 50), which were randomly divided into four groups. The control group (n = 5) received no treatment, while all other groups (n = 15 each) were exposed to 4NQO via drinking water. One group received only 4NQO, another received 4NQO followed by localized radiotherapy (16 Gy) to the oral region, and the final group received photobiomodulation before radiotherapy using a 660 nm laser (9 J, 300 J/cm²). Histological and immunohistochemical analyses (VEGF, Bax) were performed to assess tissue response and molecular changes. Ethical approval: nº001/2023. PBM associated with radiotherapy appears to have a potential radiosensitizing effect, as the results showed a decrease in the incidence of oral squamous cell carcinoma in the group in which PBM was applied prior to irradiation. The animals that did not receive PBM had a 9-fold risk of developing cancer compared to those treated with PBM before radiotherapy. VEGF expression was significantly reduced in all groups treated with 4NQO, regardless of whether radiotherapy or PBM was applied, compared to the control group. On the other hand, BAX expression increased significantly in the group subjected to the combination of PBM and radiotherapy, indicating a possible pro-apoptotic effect of PBM when associated with radiation. PBM shows potential as an effective pre-radiotherapy intervention, contributing to the prevention of HNSCC and modulation of tumor-related molecular pathways.